Healthcare provider profile · identity verified

Michael M. Uy, M.D.

Family Practice · HARTLAND, WI · NPI 1912970120

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	474	134
Atorvastatin Calcium	Atorvastatin Calcium	380	106
Amlodipine Besylate	Amlodipine Besylate	291	89
Omeprazole	Omeprazole	270	87
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	237	72
Tamsulosin Hcl	Tamsulosin Hcl	227	74
Metformin Hcl	Metformin Hcl	223	60
Lisinopril	Lisinopril	199	70
Pravastatin Sodium	Pravastatin Sodium	190	56
Pantoprazole Sodium	Pantoprazole Sodium	186	54
Losartan Potassium	Losartan Potassium	176	59
Metoprolol Succinate	Metoprolol Succinate	169	55
Simvastatin	Simvastatin	161	48
Levothyroxine Sodium	Levothyroxine Sodium	159	44
Tramadol Hcl	Tramadol Hcl	157	37
Gabapentin	Gabapentin	132	41
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	130	39
Trazodone Hcl	Trazodone Hcl	110	29
Furosemide	Furosemide	107	32
Allopurinol	Allopurinol	105	36
Escitalopram Oxalate	Escitalopram Oxalate	103	28
Lorazepam	Lorazepam	93	29
Metformin Hcl Er	Metformin Hcl	92	29
Glimepiride	Glimepiride	91	30
Meloxicam	Meloxicam	89	32
Fluticasone Propionate	Fluticasone Propionate	82	33
Hydrochlorothiazide	Hydrochlorothiazide	82	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	22
Eliquis	Apixaban	81	23
Zolpidem Tartrate	Zolpidem Tartrate	81	21
Metoprolol Tartrate	Metoprolol Tartrate	69	19
Pioglitazone Hcl	Pioglitazone Hcl	69	21
Albuterol Sulfate Hfa	Albuterol Sulfate	62	27
Atenolol	Atenolol	62	12
Potassium Chloride	Potassium Chloride	62	18
Clopidogrel	Clopidogrel Bisulfate	58	19
Warfarin Sodium	Warfarin Sodium	50	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Montelukast Sodium	Montelukast Sodium	46	14
Sertraline Hcl	Sertraline Hcl	46	16
Carvedilol	Carvedilol	45	14
Venlafaxine Hcl Er	Venlafaxine Hcl	45	15
Acetaminophen-Codeine	Acetaminophen With Codeine	43	14
Citalopram Hbr	Citalopram Hydrobromide	43	11
Duloxetine Hcl	Duloxetine Hcl	43	suppressed
Famotidine	Famotidine	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	34
Clonidine Hcl	Clonidine Hcl	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	11
Fenofibrate	Fenofibrate	34	11
Propranolol Hcl Er	Propranolol Hcl	34	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	12
Naproxen	Naproxen	32	18
Spironolactone	Spironolactone	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Lovastatin	Lovastatin	31	11
Wixela Inhub	Fluticasone Propion/Salmeterol	31	12
Bupropion Xl	Bupropion Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	11
Doxycycline Monohydrate	Doxycycline Monohydrate	29	29
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Jardiance	Empagliflozin	27	suppressed
Prednisone	Prednisone	27	15
Triamcinolone Acetonide	Triamcinolone Acetonide	27	21
Xarelto	Rivaroxaban	26	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Azithromycin	Azithromycin	24	23
Alprazolam	Alprazolam	23	suppressed
Diazepam	Diazepam	23	suppressed
Finasteride	Finasteride	23	suppressed
Pregabalin	Pregabalin	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Methylprednisolone	Methylprednisolone	20	20
Irbesartan	Irbesartan	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	17
Buspirone Hcl	Buspirone Hcl	18	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Glipizide	Glipizide	17	suppressed
Ozempic	Semaglutide	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Valsartan	Valsartan	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	11
Azelastine Hcl	Azelastine Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Clobazam	Clobazam	13	suppressed
Fycompa	Perampanel	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	13
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Risperidone	Risperidone	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error